BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8724539)

  • 1. Clonality switch in acute myeloid leukemia.
    Yin JA; Jowitt SN
    Leuk Lymphoma; 1996 Jun; 22(1-2):125-30. PubMed ID: 8724539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapsed myelodysplastic clone differs from acute onset clone as shown by X-linked DNA polymorphism patterns in a patient with acute myeloid leukemia.
    Jowitt SN; Yin JA; Saunders MJ
    Blood; 1993 Jul; 82(2):613-8. PubMed ID: 8101105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
    Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary pulmonary manifestation of extramedullary acute myelocytic leukemia].
    Florschütz A; Schumann HJ; Erikson C; Zugehör M; Rosahl W; Schreiber J
    Pneumologie; 2001 Jun; 55(6):302-5. PubMed ID: 11458438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of aggressive chemotherapy for myelodysplastic syndromes.
    Dohy H; Kyo T
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1428-34. PubMed ID: 3247817
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differentiating effect of the oral administration of vitamin D and vitamin A in acute myelocytic leukemia after BHAC-DMP therapy].
    Yamane T; Furukawa Y; Inoue T; Sagawa H; Yokomatsu Y; Kishida T; Sasaki A; Kojima K; Sannomiya Y; Yoshikawa T
    Rinsho Ketsueki; 1988 May; 29(5):765-8. PubMed ID: 3216506
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    Dunphy CH; Kitchen S; Saravia O; Velasquez WS
    Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse].
    Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y
    Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
    Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
    Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular pharmacokinetics of daunomycin in human leukemic blasts in vitro and in vivo.
    Scheulen ME; Kramer B; Skorzec M; Reich WK
    Haematol Blood Transfus; 1990; 33():122-8. PubMed ID: 2323624
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
    Nara N
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
    [No Abstract]   [Full Text] [Related]  

  • 13. Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors.
    Weinstein H; Grier H; Gelber R; Camitta B; Link M; Delorey M; Price K
    Haematol Blood Transfus; 1987; 30():88-92. PubMed ID: 3476388
    [No Abstract]   [Full Text] [Related]  

  • 14. Nine years interval between first and second bone marrow transplantations and subsequent long-term survival--a case of acute myeloid leukemia with MLL-AF6 fusion gene.
    Yokoyama Y; Suzukawa K; Okoshi Y; Nanmoku T; Obara N; Enami T; Hasegawa Y; Chiba S
    Ann Hematol; 2012 Sep; 91(9):1491-3. PubMed ID: 22307741
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow biopsy during induction chemotherapy for acute myeloid leukaemia identifies only 50% of patients with resistant disease.
    Roberts MM; Juttner CA; To LB; Kimber RJ
    Leuk Res; 1988; 12(10):817-21. PubMed ID: 3199841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
    Brown SA; Czepulkowski B; Ireland R
    Leuk Res; 1996; 20(11-12):987-8. PubMed ID: 9009258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
    Redei I; Mangan KF; Ming PL; Mullaney MT; Rao PN; Goldberg SL; Klumpp TR
    Bone Marrow Transplant; 1997 Mar; 19(5):521-3. PubMed ID: 9052924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histomorphologic study of bone marrow in acute leukemia following chemotherapy and autologous bone marrow transplantation.
    Muretto P; Izzi T; Grianti C; Moretti L
    Tumori; 1983 Jun; 69(3):239-48. PubMed ID: 6346621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
    Mantadakis E; Danilatou V; Stiakaki E; Paterakis G; Papadhimitriou S; Kalmanti M
    Pediatr Blood Cancer; 2007 Mar; 48(3):354-7. PubMed ID: 16206214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
    J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.